LONDON: The European Medicine Agency has recommended to approve the modern Covid-19 vaccine for children aged 12 to 17 years, first shots have been authorized for people under 18 years.
In a decision on Friday, the UE drug regulator said in more than 3,700 children aged 12 to 17 years showed that modern vaccines – have provided ok for adults throughout Europe – produce comparable antibody responses.
Until now, vaccines made by Pfizer and German partners Biontech have become the only choice for children in North America and Europe.
US food and drug administration is currently considering whether to extend the use of modern vaccines for children under 18 years.
With global vaccine equipment is still strict, most of the world is still struggling to immunize adults.
US and European regulators are careful that modern vaccines and pfizers appear related to a very rare reaction in adolescents and young adults – chest pain and heart inflammation.